Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? The Lancet Oncol 7 69-76

[2] Brendan MJ(2003)The etiology, clinical presentation and management of pseudomyxoma peritonei Surg Oncol Clin N Am 12 585-603

[3] Cecil TD(1995)Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol 19 1390-408

[4] Ronnett BM(1999)Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women Am J Pathol 154 1849-55

[5] Zahn CM(2002)Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2 Arch Pathol Lab Med 126 837-41

[6] Kurman RJ(1994)Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 112-9

[7] Kass ME(2005)Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 300-8

[8] Sugarbaker PH(2003)Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases Am J Surg Pathol 27 1089-103

[9] Shmookler BM(1995)Peritonectomy procedures Ann Surg 221 29-42

[10] Szych C(1999)Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 727-31

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? The Lancet Oncol 7 69-76

[2] Brendan MJ(2003)The etiology, clinical presentation and management of pseudomyxoma peritonei Surg Oncol Clin N Am 12 585-603

[3] Cecil TD(1995)Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol 19 1390-408

[4] Ronnett BM(1999)Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women Am J Pathol 154 1849-55

[5] Zahn CM(2002)Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2 Arch Pathol Lab Med 126 837-41

[6] Kurman RJ(1994)Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 112-9

[7] Kass ME(2005)Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 300-8

[8] Sugarbaker PH(2003)Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases Am J Surg Pathol 27 1089-103

[9] Shmookler BM(1995)Peritonectomy procedures Ann Surg 221 29-42

[10] Szych C(1999)Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 727-31